Skip to main content
. 2013 Jun 24;5:257–269. doi: 10.2147/CEOR.S44855

Figure 1.

Figure 1

Annual treatment cost with Eligard® 1 M, 3 M, and 6 M in the nine analyzed countries and Germany.

Notes: *Values for Germany were extracted from Odeyemi et al35 (2007 analysis) and inflated to 2011. Error bars correspond to 95% uncertainty intervals. Registered trademarks of Eligard®, Sanofi S.A./Tolmar Therapeutics Inc (Fort Collins, CO, USA).

Abbreviations: 1 M, 1-monthly; 3 M, 3-monthly; 6 M, 6-monthly.